CHINWENDU CHUKWUDIKE: Open Payments
NPI 1982176020 · NEW LONDON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 11 payments from 6 companies in 2025. Trend: 2023 $19 · 2024 $214 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Neurocrine BioSciences, Inc. | 2 | $61 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Indivior Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
Products named: REXULTI, INGREZZA, AUSTEDO XR, Auvelity, SUBLOCADE, CAPLYTA.
Industry payments across CT — which companies pay providers there.
